학술논문

Universal Updated Phase 1 Data Highlights Role of Allogeneic Anti-BCMA ALLO-715 Therapy for Relapsed/Refractory Multiple Myeloma
Document Type
Abstract
Source
In Blood 15 November 2022 140 Supplement 1:4620-4622
Subject
Language
ISSN
0006-4971